A7S-30919-02577
3 vaccinations
9 coded responses
32 check-ins
9 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 838 / ID
- Registered
- 2020-12-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-22
Registered in v-safe
-
2020-12-22
Dose 1 — Pfizer-BioNTech
- 2020-12-22
- 2020-12-23
- 2020-12-24
- 2020-12-25
- 2020-12-26
- 2020-12-27
- 2020-12-28
- 2020-12-29
- 2021-01-05
-
2021-01-12
Dose 2 — Pfizer-BioNTech
- 2021-01-12
-
2021-01-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-13
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-14
Survey response — days 1–6 daily, dose 2MedDRA: Hyperhidrosis, Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to workFree text: Swollen axillary lymph nodes (on the injection side). Waves of sweating.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-14
-
2021-01-15
Survey response — days 1–6 daily, dose 2MedDRA: Axillary pain, Hypoaesthesia, Lymphadenopathy, Paraesthesia — Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Swollen axillary lymph nodes and tenderness with numbness and tingling to fingertips (injection extremity).MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-15
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-16
Survey response — days 1–6 daily, dose 2MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tirednessFree text: Axillary lymph node swelling and tenderness on injection side.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-17
Survey response — days 1–6 daily, dose 2MedDRA: Hypoaesthesia, Lymphadenopathy, Paraesthesia — Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tirednessFree text: Axillary and surrounding area lymph node swelling with numbness and tingling down to fingertips (on injection side only).MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-18
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tirednessFree text: Axillary lymph node and surrounding area swelling (injection side)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-19
Survey response — day 7, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tirednessFree text: Axillary and surrounding area lymph node swelling (injection side).MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-26
- 2021-02-02
- 2021-02-09
-
2021-02-16
Survey response — day 35, dose 2MedDRA: Abdominal pain, Diarrhoea — Feeling: FairFree text: Loose stool with abdominal cramping.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-23
- 2021-04-13
- 2021-07-13
-
2021-09-09
Dose 3 — Pfizer-BioNTech
-
2021-09-28
Survey response — day 14, dose 3MedDRA: Chills, Headache, Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth, Myalgia, Nausea, Pyrexia, Tenderness, Vertigo, Vomiting — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Fever, chills, headache, muscle aches, nausea, sore arm at injection site, visible localized swelling w/heat, redness & tenderness in axilla (tennis ball size), and severe vertigo w/vomiting. All lasting 1 week.MedDRA releases: 2024-11 · check-in free text available
- 2021-09-30
- 2021-10-07
- 2021-10-14
- 2021-10-21
-
2021-12-10
Survey response — 3 months, dose 3MedDRA: Ventricular extrasystoles — Feeling: Fair · Be unable to work or attend schoolFree text: Suddent/new onset of PVC's.MedDRA releases: 2024-11 · check-in free text available
- 2022-03-10
- 2022-09-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech | |
| 3 | 2021-09-09 | Pfizer-BioNTech | No |
Call center
3 call center cases
3 priority 2/3 (triaged and no follow up)
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Swollen axillary lymph nodes (on the injection side). Waves of sweating.
Systemic reaction (other): Swollen axillary lymph nodes and tenderness with numbness and tingling to fingertips (injection extremity).
Systemic reaction (other): Axillary lymph node swelling and tenderness on injection side.
Systemic reaction (other): Axillary and surrounding area lymph node swelling with numbness and tingling down to fingertips (on injection side only).
Systemic reaction (other): Axillary lymph node and surrounding area swelling (injection side)
Release 2 — day 7, dose 2
Systemic reaction (other): Axillary and surrounding area lymph node swelling (injection side).
Release 4 — day 35, dose 2
Symptoms: Loose stool with abdominal cramping.
Release 9 — day 14, dose 3
Symptoms: Fever, chills, headache, muscle aches, nausea, sore arm at injection site, visible localized swelling w/heat, redness & tenderness in axilla (tennis ball size), and severe vertigo w/vomiting. All lasting 1 week.
Release 10 — 3 months, dose 3
Symptoms: Suddent/new onset of PVC's.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal pain | ✓ | ✓ | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Injection site erythema | · | · | ✓ |
| SD | Injection site pain | · | · | ✓ |
| SD | Injection site swelling | · | · | ✓ |
| SD | Injection site warmth | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Tenderness | · | · | ✓ |
| SD | Ventricular extrasystoles | · | · | ✓ |
| SD | Vertigo | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
| SRO | Axillary pain | ✓ | ✓ | ✓ |
| SRO | Hyperhidrosis | ✓ | ✓ | ✓ |
| SRO | Hypoaesthesia | ✓ | ✓ | ✓ |
| SRO | Lymph node pain | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Paraesthesia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release